MAM
GMAB icon

Meeder Asset Management’s Genmab GMAB Stock Holding History

Meeder Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12
Closed – – 1265
2022
Q3 		$0 Buy
12
+6
+100% +$211 ﹤0.01% 2227
2022
Q2 		$0 Hold
6
– – ﹤0.01% 2271
2022
Q1 		$0 Buy
6
+1
+20% +$34 ﹤0.01% 2391
2021
Q4 		$0 Hold
5
– – ﹤0.01% 1634
2021
Q3 		$0 Hold
5
– – ﹤0.01% 2535
2021
Q2 		$0 Hold
5
– – ﹤0.01% 2565
2021
Q1 		$0 Hold
5
– – ﹤0.01% 2394
2020
Q4 		$0 Hold
5
– – ﹤0.01% 2007
2020
Q3 		$0 Buy
+5
New +$181 ﹤0.01% 2246
2020
Q1 		– Sell
-57
Closed -$1K – 2392
2019
Q4 		$1K Buy
+57
New +$1.24K ﹤0.01% 2134

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Meeder Asset Management's GMAB Position: Q4 2022 in Review

Meeder Asset Management sold out of Genmab (GMAB) in Q4 2022, closing a stake of 12 shares.

Meeder Asset Management first reported a position in GMAB in Q4 2019 and held it in 10 quarters. The position peaked at $1K in Q4 2019. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.

  • Meeder Asset Management reported no remaining Genmab position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 12 Genmab shares in Q4 2022.
  • Meeder Asset Management first reported a position in Genmab in Q4 2019 and held it in 10 quarters.
  • Meeder Asset Management's Genmab position peaked at $1K in Q4 2019.
  • 237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.